Oral human spasmolytic polypeptide protects against aspirin- induced gastric injury in rats

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 4, 1998, Pages 363-370

  Cook, Gregory A ^a   Thim, Lars ^b   Yeomans, Neville D ^a   Giraud, Andrew S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Aspirin; Cytoprotection; Gastric mucosa; Restitution; Spasmolytic polypeptide

Indexed keywords

ACETYLSALICYLIC ACID; INTESTINAL TREFOIL FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT; SPASMOLYTIC AGENT; SPASMOLYTIC POLYPEPTIDE; TREFOIL PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; DRUG INDUCED DISEASE; DRUG MECHANISM; INFLAMMATION; INTRAGASTRIC DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SPASMOLYSIS; STOMACH MUCOSA INJURY; STOMACH PROTECTION; STOMACH ULCER;

EID: 0031978156     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00647.x     Document Type: Article

References (37)

1. Jorgensen KD, Diamant B, Jorgensen KH, Thim L. Pancreatic spasmolytic polypeptide (PSP): III. Pharmacology of a new porcine pancreatic polypeptide with spasmolytic and gastric acid secretion inhibitory effects. Regul. Pept. 1982; 3: 31-43.
2. Chinery R, Bates PA, De A, Fremont PS. Characterisation of the single copy trefoil peptides intestinal trefoil factor and pS2 and their ability to form covalent dimers. FEBS Lett. 1995; 357: 50-4.
3. Thim L, Woldike HF, Nielson PF, Christensen M, Lynch-Devaney K, Podolsky DK. Characterization of human and rat intestinal trefoil factor produced in yeast. Biochemistry 1995; 34: 4757-64.
4. Carr MD. 1H NMR-based determination of the secondary structure of porcine pancreatic spasmolytic polypeptide: one of a new family of "trefoil" motif containing cell growth factors. Biochemistry 1992; 31: 1998-2004.
5. Carr MD, Bauer CJ, Gradwell MJ, Feeney J. Solution structure of a trefoil-motif-containing cell growth factor, porcine spasmolytic protein. Proc. Natl Acad. Sci. USA 1994; 91: 2206-10.
6. Gajhede M, Petersen TN, Henriksen A et al. Pancreatic spasmolytic polypeptide: first three dimensional structure of a member of the mammalian trefoil family of peptides. Structure 1993; 1: 253-62.
7. De A, Brown DG, Gorman MA, Carr M, Sanderson MR, Freemont PS. Crystal structure of a disulfide-linked "trefoil" motif found in a large family of putative growth factors. Proc. Natl Acad. Sci. USA 1994; 91: 1084-8.
8. Hanby AM, Poulsom R, Singh S, Elia G, Jeffery RE, Wright NA. Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology 1993; 105: 1110-16.
9. Jeffrey GP, Dates PS, Wang TC, Babyatsky MW, Brand SJ. Spasmolytic polypeptide: a trefoil peptide secreted by rat gastric mucous cells. Gastroenterology 1994; 106: 336-45.
10. Cook GA, Familari M, Gibson PR, Giraud AS. Trefoil peptide expression by macrophages: implications for gastrointestinal repair. Gastroenterology 1997; 112: A696.
11. Rio M-C, Bellocq JP, Daniel JY et al. Breast cancer-associated pS2 protein: Synthesis and secretion by normal stomach mucosa. Science 1988; 241: 705-8.
12. Probst JC, Landgraf R, Stalla GK, Zetzsche T. Differential distribution of trefoil polypeptides in the hypothalamo-hypophyseal system and immune system. Regul. Pept. 1996; 64: A156.
13. Hirota M, Miyashita S, Hayashi H, Furukawa Y, Hayashi K. pS2 gene especially expressed in the late G1/S phase of mouse astrocytes. Neurosci. Lett. 1994; 171: 49-51.
14. Suemori S, Lynch-Devaney K, Podolsky DK. Identification and characterization of rat intestinal trefoil factor: tissue and cell-specific member of the trefoil protein family. Proc. Natl Acad. Sci. USA 1991; 88: 11017-21.
15. Hauser F, Poulsom R, Chinery R et al. hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer associated cell lineage and the uterus. Proc. Natl Acad. Sci. USA 1993; 90: 6961-5.
16. Chinery R, Poulsom R, Robert LA et al. Localization of intestinal trefoil-factor mRNA in rat stomach and intestine by hybridization in situ. Biochem. J. 1992; 285: 5-8.
17. Mashimo H, Podolsky DK, Fishman MC. Structure and expression of murine intestinal trefoil factor: high evolutionary conservation and post-natal expression. Biochem. Biophys. Res. Commun. 1995; 210: 31-7.
18. Taupin DR, Pang KC, Green SP, Giraud AS. The trefoil peptides spasmolytic polypeptide and intestinal trefoil factor are major secretory products of the rat gut. Peptides 1995; 16: 1001-5.
19. Cook GA, Yeomans ND, Giraud AS. Temporal expression of spasmolytic polypeptide and intestinal trefoil factor following gastric ulceration in the transforming growth factor-alpha gene deficient mouse. Am. J. Physiol. 1997; 35: G1540-9.
20. Probst JC, Zetzsche T, Weber M et al. Human intestinal trefoil factor is expressed in human hypothalamus and pituitary: evidence for a novel neuropeptide. FASEB J. 1996; 10: 1518-23.
21. Wright NA, Pike C, Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 1990; 343: 82-5.
22. Wright NA, Poulsom R, Stamp GWH et al. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J. Pathol 1990; 162: 279-84.
23. Rio M-C, Chambon P.The pS2 gene, mRNA, and protein: a potential marker for human breast cancer. Cancer cells 1990; 2: 269-74.
24. Playford RJ, Marchbank T, Chinery R et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 1995; 108: 108-16.
25. Babyatsky MW, DeBeaumont M, Thim L, Podolsky DK. Oral trefoil peptides protect against ethanol and indomethacin induced gastric injury in rats. Gastroenterology 1996; 110: 489-97.
26. Dignass A, Lynch-Devaney K, Kindon H, Thim L, Podolsky DK. Trefoil peptides promote epithelial migration through a transforming growth factor β-independent pathway. J. Clin. Invest. 1994; 94: 376-83.
27. Kindon H, Pothoulakis C, Thim L, Lynch-Devaney K, Podolsky DK. Trefoil peptides protection of intestinal epithelial barrier function: Co-operative interaction with mucin glycoprotein. Gastroenterology 1996; 109: 516-23.
28. Playford RJ, Marchbank T, Goodlad RA et al. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc. Natl Acad. Sci. USA 1996; 93: 2137-42.
29. Lefebvre O, Chenard M-P, Masson R et al. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 1996; 274: 259-62.
30. Mashimo H, Wu D-C, Podolsky DK, Fishman MC. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996; 274: 262-5.
31. Rio M-C, Chenard M-P, Wolf C et al. Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology 1991; 100: 375-9.
32. Alison MR, Chinery R, Poulsom R, Ashwood P, Longcroft JM, Wright NA. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach. J. Pathol. 1995; 175: 405-14.
33. Cook GA, Elliott SL, Skeljo MV, Giraud AS, Yeomans ND. Correlation between transmucosal potential difference and morphological damage during aspirin injury of gastric mucosa in rats. J. Gastroenterol. Hepatol. 1996; 11: 264-9.
34. 2. Dig. Dis. Sci. 1997; 42: 654-60.
35. Thim L, Norris K, Norris F et al. Purification and characterization of the trefoil peptide human spasmolytic polypeptide (hSP) produced in yeast. FEBS Lett. 1993; 318: 345-52.
36. Sands BE, Podolsky DK. The trefoil peptide family. Ann. Rev. Physiol. 1996; 58: 253-73.
37. Yeomans ND, St John DJB, de Boer WGRM. Regeneration of gastric mucosa after aspirin-induced injury in the rat. Am. J. Dig. Dis. 1973; 18: 773-80.